A federal appeals court on Wednesday ruled in favor of restricting a commonly used abortion drug, setting up what could be the next major Supreme Court case with national implications for abortion.
A three-judge panel of the U.S. Court of Appeals for the 5th Circuit heard oral arguments in May in a case brought by conservative medical provider groups who oppose the Food and Drug Administration’s 2000 approval of mifepristone, which is used to end pregnancies.
Abortion opponents have criticized the drug since its approval, and mifepristone is subject to tighter regulation than most other FDA-approved medications.
